Version v1 · Effective 24 July 2026
Overview
These terms govern your use of the Longaevitas Health platform, a technology platform for doctor-led personalised preventative care and longevity planning. Longaevitas Health is not a healthcare provider; clinical decisions remain with a supervising HPCSA-registered doctor and your own treating GP or specialist.
By creating an account, purchasing a VitaPrint Cycle, or otherwise using the platform, you agree to these terms, the and the Medicolegal Terms set out below . You must seek diagnosis, treatment and prescriptions from your own GP or specialist; the platform provides educational outputs and doctor-led guidance, not medical advice from the platform itself. To the maximum extent allowed by the Consumer Protection Act 68 of 2008 and other South African law, our liability for use of the platform is limited accordingly.
Who may use the platform
You must be 18 years or older and have full legal capacity to contract to create an account, purchase a VitaPrint Cycle, redeem a gift code, or submit health information to us. The platform is built for adults and we do not offer paediatric assessment, testing or clinical review. Information about a person under 18 is special personal information under the Protection of Personal Information Act, and we do not knowingly process it. If we find that an account belongs to a person under 18, we will suspend it, stop processing, and delete the information unless the law requires us to keep it.
You may not create an account on behalf of another adult, or submit another person's biomarker results or health history as your own. Each account represents one person, and the analysis is only valid for the person whose measurements were submitted.
Payment and refunds
Each VitaPrint Cycle starts with payment. You will be asked to pay for your cycle before you can complete your assessment, add your body measurements, download your lab form or upload your biomarker results. Payment can be made once-off for a single VitaPrint Cycle, or as a VitaPrint Cycles subscription that renews every two cycles.
You can request a partial refund of 80% within 14 days of purchase, as long as your doctor-led VitaPrint Analysis has not yet been delivered. The 20% we retain covers payment processing and the clinical time already reserved for your cycle. After 14 days, or once your analysis has been delivered, cycles are non-refundable. Any unused cycles remain in your account and do not expire, so you can complete them whenever you are ready. You may cancel a VitaPrint Cycles subscription at any time to stop future renewals; cycles you have already paid for stay available to you. To request a refund, contact our support team. Full detail, including your cooling-off rights, is set out in the Refunds and Cancellations Policy below .
Supplier information
Disclosed in terms of section 43 of the Electronic Communications and Transactions Act 25 of 2002. Longaevitas Health (Pty) Ltd, registration number 2025/413084/07, a private company incorporated in the Republic of South Africa, of 18 Kent Road, Dunkeld West, Randburg, 2196. Contact: support@longaevitashealth.com. Website: longaevitashealth.com. We provide access to a doctor-led preventative care and longevity-planning platform. Prices are quoted in South African Rand, include value-added tax where applicable, and are shown in full before you confirm payment. Payment is taken by our third-party payment processor over a secure connection; we do not store your card details. These terms, the Privacy Policy, the Medicolegal Terms and the Refunds and Cancellations Policy together form the full agreement, and each is available on this site at any time for you to read, download and store.
Cooling-off right
Section 44 of ECTA allows you to cancel an electronic transaction without reason or penalty within seven (7) days of the transaction and receive a full refund. Under section 42(2) of ECTA that right falls away for services that have begun to be performed with your express agreement. Your cycle begins the moment you start your assessment, add body measurements, generate your laboratory form, or upload biomarker results, and by doing any of those things you expressly agree that performance has begun. Our own refund window continues to apply after that point.
Subscription renewal and cancellation
A VitaPrint Cycles subscription renews automatically every two cycles at the rate published at the time of renewal. In terms of section 14(2)(c) of the Consumer Protection Act 68 of 2008, we will notify you in writing not more than 80 and not less than 40 business days before each renewal date, telling you the renewal date, the amount that will be charged, any change to that amount, and how to cancel. Any discount applied to your subscription is re-quoted at the rate current on the renewal date.
You may cancel at any time without penalty. Cancellation takes effect twenty (20) business days after we receive your notice, or sooner if we can process it earlier, and stops all future renewals. Cycles you have already paid for remain in your account and do not expire. We may cancel or decline to renew on 20 business days written notice, in which case we refund any cycle you have paid for and not used, in full.
Refunds and cancellations policy
1. What this policy covers
This policy explains when you can cancel a purchase, when you can claim a refund, and how we handle each request. It applies to single VitaPrint Cycles, VitaPrint Cycles subscriptions, gift codes, and question top-ups bought through the Longaevitas Health platform. It is written to comply with the Consumer Protection Act 68 of 2008 ("CPA") and the Electronic Communications and Transactions Act 25 of 2002 ("ECTA"). Nothing in this policy limits any right you have under those Acts.
Longaevitas Health does not sell, supply, dispense or ship supplements or any other health product. Purchases from retailers or wellness partners mentioned on the platform are separate transactions with that retailer, and their own refund policy applies.
2. Cooling-off period for online purchases
Because you buy from us electronically, section 44 of ECTA gives you the right to cancel a transaction without reason and without penalty within seven (7) days of the date of the transaction, and to receive a refund of all payments made.
There is one important qualification, which we ask you to read carefully. Under section 42(2) of ECTA, the cooling-off right falls away for services that have begun to be performed with your express agreement before the end of the seven-day period. Your VitaPrint Cycle begins the moment you start your health assessment, add body measurements, generate your laboratory form, or upload biomarker results. If you do any of those things within the cooling-off period, you are expressly agreeing that the service has begun and the ECTA cooling-off right no longer applies. Our own refund window in section 3 continues to apply after that point, and it is more generous than the law requires.
To use the cooling-off right, email support@longaevitashealth.com within seven days of payment with your order reference. We will refund the full amount to the original payment method within 30 days.
3. Our refund window
Outside the cooling-off period, you can request a refund of 80% of what you paid, within 14 days of purchase, as long as your doctor-led VitaPrint Analysis has not yet been delivered.
The 20% we retain is a reasonable charge for payment processing already incurred and clinical capacity reserved for your cycle, as contemplated by section 17 of the CPA. It is not a penalty.
Refunds are not available once either of the following happens:
- Your doctor-led VitaPrint Analysis has been delivered to your account. At that point the clinical work has been performed in full.
- More than 14 days have passed since payment.
Unused cycles never expire. If you no longer want a refund, the cycle simply stays in your account until you are ready to use it.
4. Cancelling a VitaPrint Cycles subscription
You may cancel your subscription at any time, for any reason, without penalty. Cancellation stops all future renewals. Cycles you have already paid for remain in your account and stay available to you.
Cancel from your account settings, or email support@longaevitashealth.com. We will confirm the cancellation in writing. In line with section 14 of the CPA, cancellation takes effect twenty (20) business days after we receive your notice, or sooner if we are able to process it earlier, and we will not charge a cancellation penalty.
5. Automatic renewal
A VitaPrint Cycles subscription renews automatically every two cycles at the rate published at the time of renewal. We will notify you in writing not more than 80 and not less than 40 business days before each renewal date, setting out the renewal date, the amount that will be charged, any change to that amount, and how to cancel. This notice is given in terms of section 14(2)(c) of the CPA.
If a discount was applied to your subscription, for example an ambassador code or a medical aid partner rate, that discount is re-quoted at the rate current on the renewal date. Your renewal notice will show the exact amount.
6. Failed and duplicate payments
Duplicate charges and payments taken in error are refunded in full, without deduction, as soon as we confirm them. Contact support with the transaction reference and we will investigate within five business days.
7. Gift codes
Gift codes may be refunded in full while unredeemed, within the window in section 3. Once redeemed by a recipient, the refund rules for the underlying cycle apply and any request must come from the person who redeemed it.
8. If your cycle cannot be completed
If we are unable to deliver your doctor-led VitaPrint Analysis for a reason within our control, you may choose a full refund of that cycle or a replacement cycle at no charge. Delays caused by laboratory turnaround, or by results or information we are waiting on from you, are not treated as a failure to deliver.
9. How to claim, and how long it takes
Email support@longaevitashealth.com with your name, order reference and the reason for the request. We acknowledge within two business days and decide within ten business days. Approved refunds are paid to the original payment method within 30 days of approval.
10. If you are not satisfied
If you are unhappy with our decision, you may escalate to the National Consumer Commission or to the Consumer Goods and Services Ombud. This policy does not remove or limit your rights under the CPA or ECTA.
Longaevitas Health (Pty) Ltd, registration number 2025/413084/07, 18 Kent Road, Dunkeld West, Randburg, 2196. This policy is governed by the laws of the Republic of South Africa.
Medicolegal terms
1. What Longaevitas Health is
Longaevitas Health (Pty) Ltd operates a technology platform for doctor-led personalised preventative care and longevity planning. The platform combines self-reported health assessments, body metrics, and biomarker results, and presents them through a VitaPrint, system scores, and Vita (your longevity co-pilot).
Longaevitas Health is not a hospital, clinic, emergency service or healthcare provider. The platform provides a structured workflow; clinical decisions sit with a supervising HPCSA-registered doctor and, ultimately, with your own treating GP or specialist.
2. Wellness proxy, not a diagnosis
Your VitaPrint, system scores, biomarker context, personalised plan and Vita responses are wellness and educational proxies. They are not a medical diagnosis, prescription, treatment plan, or a doctor-patient relationship with the platform itself.
- System scores are directional wellness proxies calculated from your self-reported answers and results.
- Biomarker interpretations are educational context guided by doctor-developed protocols.
- Vita responses are educational only and drawn from doctor-developed content and your own data.
3. Doctor-led workflow, doctor-owned decisions
Every VitaPrint Analysis is doctor-led and is signed off by a HPCSA-registered doctor before it is released to you. Longaevitas doctors define the clinical rules, longevity reference ranges and protocols that generate each analysis, and the signing doctor acts under their own professional judgement and professional indemnity. Longaevitas Health does not practise medicine and does not override clinical decisions made by that doctor or by your own GP.
Two release paths apply. Where every body metric and biomarker falls outside the abnormal band and no safety flag is raised, your analysis is released under those doctor-set protocols and signed off by the clinical head of your allocated care team. A random sample of these releases, currently at least one in ten, is reviewed retrospectively by that clinical head for clinical quality. Where any result falls into the abnormal band, or an escalation, adverse event or referral flag is raised, a supervising doctor personally reviews and signs your analysis before it is released.
Referrals, prescriptions, diagnosis and treatment remain the responsibility of a treating clinician. The platform surfaces GP referral suggestions only when configured to do so by the supervising doctor and, in the case of biomarkers, only when results fall into the abnormal band.
3A. Asynchronous, non-face-to-face care
Longaevitas Health operates asynchronously. Your measurements, assessment answers and biomarker results are analysed against protocols set by HPCSA-registered doctors, and a doctor signs off the resulting written VitaPrint Analysis and plan in their own time. There is no physical examination, no real-time consultation and no continuous monitoring, and the platform is not staffed outside ordinary working hours.
This model has real limits. A doctor working from written information alone cannot examine you, cannot observe signs that only appear in person, and relies entirely on the accuracy and completeness of what you and the laboratory provide. Conditions that need examination, imaging, or in-person assessment fall outside what this platform can do, and a supervising doctor may decline to comment and refer you to in-person care instead.
Supervising doctors practise under HPCSA registration and the HPCSA telemedicine and ethical guidelines, and each remains individually accountable for their own clinical work and indemnity. Their registration category and number are available on request from support@longaevitashealth.com.
3B. Scope of practice
What the platform and its supervising doctors do: review your submitted measurements and results, interpret them against doctor-developed protocols, produce a VitaPrint Analysis, and issue a personalised preventative care and longevity plan covering nutrition, movement, sleep, stress, screening and supplement education.
What they do not do: diagnose disease, prescribe or dispense medication, treat acute illness, manage chronic disease, provide mental-health crisis support, sell or ship supplements, order follow-up imaging or specialist procedures, or take over any part of the care your own GP or specialist provides.
3C. Escalation of abnormal results
Where a biomarker falls into the abnormal band, the platform flags it for the supervising doctor and raises a GP referral suggestion. The supervising doctor reviews the flag and may issue a referral letter for you to take to your own GP or specialist. Results in the suboptimal band do not trigger a referral; they are handled as educational context in your plan.
Escalation happens within the platform's ordinary working-hours review window and is not immediate. It is not a substitute for emergency care, and the platform does not contact your GP, your family, or emergency services on your behalf. If a result concerns you, or if you develop symptoms while waiting for review, seek in-person medical care without waiting for the platform.
You remain responsible for acting on a referral. Longaevitas Health cannot compel a consultation, cannot book one for you, and is not liable for harm arising from a referral you choose not to act on.
4. What you must still do yourself
- Maintain an ongoing relationship with your own GP or specialist for diagnosis, treatment and prescriptions.
- Seek urgent, in-person medical care for any symptom that could indicate an emergency.
- Never delay, avoid or change medical treatment based on anything you read on the platform.
- Give accurate information; personalised outputs are only as reliable as the answers and results you provide.
5. Emergencies
The platform is not an emergency service and is not monitored in real time. In an emergency, contact your nearest emergency service immediately (in South Africa, dial 10177 for ambulance or 112 from a mobile phone).
5A. How Vita learns from member trends
Vita is the platform assistant. To keep its educational content current, Longaevitas analyses de-identified trends across the member community, including changes in assessment answers, body metrics, biomarker values, and outcomes following supplement or plan recommendations. Cohort-level insights produced from this analysis inform what Vita may surface and what doctor-led practitioners may consider.
Cohort insights are educational, not clinical. They do not diagnose, prescribe or override the judgement of a supervising doctor or your own treating clinician. Direct identifiers are removed before your information is used for cohort learning, and no individual member is identifiable in the aggregated results. Longaevitas does not sell your information and does not use it to train third-party artificial intelligence models.
Cohort learning is on by default. Members may opt out at any time from Account > Privacy. Opting out excludes future data from cohort learning and has no effect on the doctor-led care they receive.
6. Limits of liability
To the maximum extent permitted by the Consumer Protection Act 68 of 2008 and other applicable South African law, Longaevitas Health is not liable for loss or harm arising from reliance on educational outputs of the platform, from clinical decisions made by a supervising doctor or your own treating clinician, or from your failure to seek independent medical care where indicated.
7. Regulation and complaints
Longaevitas doctors are registered with the Health Professions Council of South Africa ("HPCSA") and are bound by the HPCSA ethical rules, including those governing telemedicine and asynchronous care. Longaevitas Health (Pty) Ltd is the platform operator and is not itself a registered healthcare practitioner.
Step 1, raise it with us. Send any complaint, clinical or otherwise, to support@longaevitashealth.com with your name, the cycle or analysis concerned, and what went wrong. We acknowledge within 5 business days.
Step 2, clinical review. Complaints involving clinical judgement, the content of a VitaPrint Analysis, a referral decision or a doctor's conduct are referred to a clinical head who was not involved in your care. You receive a written outcome within 30 business days, or an explanation of the delay and a revised date. Where a complaint suggests a possible adverse event, it is logged and reviewed through our clinical quality process.
Step 3, independent escalation. You do not have to exhaust our internal process first, and nothing here limits your rights. You may lodge a complaint about a practitioner directly with the HPCSA (Legal and Regulatory Affairs, PO Box 205, Pretoria 0001, legalmed@hpcsa.co.za, www.hpcsa.co.za). Complaints about privacy or personal information may go to the Information Regulator (South Africa) as set out in our Privacy Policy. Complaints about the commercial transaction may go to the National Consumer Commission.
We do not penalise, suspend or refuse service to a member because they have lodged a complaint.
8. Changes to these terms
Medicolegal terms are versioned. Material changes are notified in-app and take effect on the date shown at the top of this page. Continued use of the platform after the effective date constitutes acceptance of the updated terms.
This page is drafted for South African law (National Health Act 61 of 2003, HPCSA ethical rules, POPIA, ECTA and the Consumer Protection Act). It is subject to review by our appointed South African healthcare attorney; the current version is provided for transparency and does not constitute legal advice.
1. Introduction and Definitions
Who this consent is between, the laws that govern it, and the defined terms used throughout.
This Member Consent ("Consent") is a binding agreement between you ("Member", "you") and Longaevitas Health (Pty) Ltd (Registration Number 2025/413084/07), a private company incorporated in the Republic of South Africa with its registered office at 18 Kent Road, Dunkeld West, Randburg, 2196 ("Longaevitas", "we", "us", "our").
In this Consent: "Services" means the Longaevitas preventative healthcare and longevity-planning platform, including the Health Assessment, VitaPrint Cycles, Doctor-led VitaPrint Analysis, educational supplement guidance, partner information, and any associated content or communications. Longaevitas does not sell, supply, dispense, ship or fulfil supplements or any other health product; "VitaPrint" means the personalised preventative healthcare record generated for you within the Services; "Practitioner" means a medical doctor registered with the Health Professions Council of South Africa ("HPCSA") who reviews your information through the Services; "Personal Information" and "Special Personal Information" have the meanings given in the Protection of Personal Information Act 4 of 2013 ("POPIA"); "ECTA" means the Electronic Communications and Transactions Act 25 of 2002; "CPA" means the Consumer Protection Act 68 of 2008; and "National Health Act" means the National Health Act 61 of 2003.
This Consent must be read together with the Longaevitas Privacy Policy, the PAIA Manual, and the applicable HPCSA ethical guidelines (including the Booklets on General Ethical Guidelines for the Healthcare Professions and on Telemedicine). To the extent of any inconsistency between this Consent and any other Longaevitas policy, this Consent prevails for matters concerning the use of the Services and the clinical relationship.
By acknowledging each section below, signing the final declaration electronically, and clicking Accept and Submit, you confirm that you have read, understood and accepted every clause of this Consent. Pursuant to section 13 of ECTA, your electronic acknowledgement and signature constitute a valid signature with the same legal effect as a handwritten signature.
2. Nature of the Service
What Longaevitas does - and does not do - for you.
Longaevitas provides a doctor-led, preventative healthcare and longevity-planning platform. The Services include: preventative health screening; longevity planning; health optimisation; identification of modifiable risk; personalised lifestyle, nutritional and supplementation guidance; and the doctor-led interpretation of health information you supply. Longaevitas is an information and planning platform: it does not sell, supply or deliver supplements or other health products, and any product you choose to purchase is bought from an independent retailer under that retailer's own terms.
The Services are designed to assist healthy and clinically stable adults to reduce future health risk through preventative measures. The Services are not intended to diagnose, treat, cure or manage acute illness; they do not replace the assessment, examination or treatment provided by your treating medical practitioners; and they do not constitute emergency medical care.
Information shared through the Services, whether in your VitaPrint, written correspondence, or supporting educational material, is provided for your personal use as part of a doctor-led preventative programme and may not be relied upon for any other purpose without independent clinical advice.
3. No Emergency Services
Longaevitas is not an emergency service. If you are in an emergency, call 112 or 10177 now.
Longaevitas is not an emergency service, an ambulance service, a hospital, a clinic, an after-hours service, or a crisis service. The Services are asynchronous and there is no guarantee of immediate response by any Practitioner or member of the Longaevitas team.
If you experience, suspect, or are at risk of a medical emergency, you must immediately telephone your nearest emergency medical service (in South Africa, 112 from a mobile telephone or 10177 from a landline), contact your treating medical practitioner, or attend the nearest emergency department. You must not wait for, or rely upon, any communication through the Services in an emergency.
4. Doctor-Led Clinical Care
Every recommendation is reviewed and approved by an HPCSA-registered Practitioner.
All clinical recommendations issued through the Services are reviewed and approved by an HPCSA-registered Practitioner before they are released to you. The Practitioner exercises independent clinical judgement and remains solely responsible for the final clinical content of your Doctor-led VitaPrint Analysis.
Automated processing and platform assistance. Longaevitas uses automated processing, including rule-based scoring and artificial intelligence, to organise your information, calculate system scores, disease-risk estimates and your Longaevitas Age, to draft educational content, and to prepare a structured briefing for the Practitioner. These outputs are preparatory and educational. They are not clinical decisions.
No decision that affects you clinically is taken solely by automated means. For the purposes of section 71 of POPIA, every clinical recommendation released to you is reviewed, amended where necessary, and approved by an HPCSA-registered Practitioner who applies independent clinical judgement. You may at any time request that a Practitioner reconsider any automated output, ask how it was arrived at, and make representations about it, by contacting support@longaevitashealth.com.
Where appropriate, the Practitioner may decline to issue a recommendation, may require additional information, or may recommend that you consult a treating medical practitioner in person.
5. Clinical Limitations
The limits of preventative care, risk scoring, and what normal results do and do not mean.
I acknowledge and accept the following clinical realities:
(a) No health assessment, biomarker panel, screening tool or risk score can detect every disease, latent condition, or future event. Many conditions cannot be diagnosed without a full in-person history, physical examination, imaging, or additional investigations.
(b) All risk scores, ranges, projections and longevity estimates are probabilistic and are derived from population-level evidence. They describe likelihood across a population and do not predict the future for any individual with certainty.
(c) Preventative care reduces risk; it cannot eliminate disease, ageing, injury or death. Adverse health events may occur despite optimal preventative care.
(d) A result reported as normal does not exclude existing or future disease and does not guarantee future health. Conditions may develop or change between assessments.
(e) All recommendations issued through the Services are based on the information available to the Practitioner at the time of review. New information, results, symptoms or circumstances may render an earlier recommendation incomplete or inappropriate.
6. Member Responsibilities
Honest disclosure of medications, conditions, allergies, pregnancy and family history.
The safety, accuracy and value of every recommendation issued through the Services depend on the information you provide. I undertake that, to the best of my knowledge:
(a) all information I supply is true, complete, current and unaltered, and I will not omit information that may be material to my health;
(b) I will disclose all prescription and over-the-counter medications I am taking, including dosages, frequencies and recent changes;
(c) I will disclose all supplements, vitamins, herbal preparations and recreational substances I am taking;
(d) I will disclose all known allergies and adverse reactions, particularly to medications, supplements or foods;
(e) I will disclose all current and previous diagnosed medical conditions, mental health conditions, and any condition under active investigation or treatment;
(f) I will disclose previous surgeries, hospital admissions, and significant medical events;
(g) I will disclose relevant family medical history where it is known to me;
(h) I will disclose pregnancy, planned pregnancy, breastfeeding, fertility treatment or any other relevant reproductive status where applicable;
(i) I will promptly inform Longaevitas of any material change in my health, medications, treatments or circumstances; and
(j) I accept that inaccurate, incomplete or out-of-date information may render a recommendation unsafe or inappropriate, and the Practitioner is entitled to rely on the information I have provided.
7. Blood Results and External Investigations
Laboratory and third-party testing has limits, and Longaevitas relies on those providers for accuracy.
Where biomarker results, imaging, genetic results or other investigations are uploaded to or generated through the Services, I acknowledge that:
(a) all laboratory and diagnostic testing has technical, biological and analytical limitations, including measurement variability, reference-range differences between laboratories, pre-analytical influences (such as fasting, hydration, time of day, recent illness, exertion or medication) and the inherent uncertainty of any test;
(b) results reflect a single point in time and may change with health status, treatment, diet, life events or natural variation;
(c) Longaevitas does not perform the laboratory or diagnostic testing itself; testing is performed by independent third-party laboratories and providers, and Longaevitas is entitled to rely upon, but does not warrant, the accuracy, completeness or timeliness of results supplied by those providers;
(d) recommendations are based only on the results actually available to the Practitioner at the time of review; and
(e) abnormal, unexpected or borderline results may require further investigation, repeat testing, or assessment by a treating practitioner; I will follow such recommendations promptly when given; and
(f) where I have obtained a laboratory request form from Longaevitas and my results have not been loaded onto the platform, the Longaevitas operations team may contact me on the mobile number I provided, may receive my results directly from the laboratory or from me, and may load those results onto my VitaPrint Cycle on my behalf so that a Practitioner can complete the analysis. This operational assistance is part of the Services and is recorded in my clinical record.
8. Lifestyle Recommendations
Nutrition, exercise, sleep, supplementation, stress, weight, performance and longevity guidance is educational and preventative.
Lifestyle recommendations issued through the Services in the fields of nutrition, exercise, sleep, supplementation, stress management, weight management, performance optimisation and longevity are educational and preventative in nature.
Implementation of any lifestyle recommendation is voluntary and is my responsibility. I will introduce changes with appropriate gradation, will discontinue any change that causes adverse effects, and will obtain in-person clinical advice before making changes that may interact with existing conditions, medications, pregnancy or planned pregnancy.
No specific health, body composition, performance or longevity outcome is promised or guaranteed by Longaevitas. Individual responses to lifestyle interventions vary widely.
9. Supplement Guidance
Longaevitas gives supplement information only. It does not sell, supply or ship supplements.
Longaevitas provides supplement guidance as information. Longaevitas does not sell, supply, dispense, compound, ship or fulfil any supplement, and does not hold stock. Where a retailer or wellness partner is named alongside a suggested active ingredient, that information is provided for convenience only. Any purchase is a separate transaction between me and that independent retailer, on that retailer's own terms, and Longaevitas is not a party to it.
Supplements suggested through the Services are intended as adjuncts to a healthy lifestyle and a doctor-led preventative programme. The decision to take, continue or discontinue any supplement is mine to make.
Individual responses to supplements vary. Supplements may interact with prescription medication, may be inappropriate during pregnancy, breastfeeding or specific clinical conditions, and may produce adverse effects. I will discuss any concern, side effect or interaction with my treating practitioner before continuing.
Product quality, labelling, safety, availability, pricing, delivery and regulatory compliance under the Medicines and Related Substances Act 101 of 1965, the Foodstuffs, Cosmetics and Disinfectants Act 54 of 1972 and the applicable South African Health Products Regulatory Authority requirements remain the responsibility of the manufacturer and the retailer from whom I purchase. Longaevitas makes no therapeutic claim beyond the educational information presented in my plan.
10. Referral Recommendations
When the Practitioner recommends consulting another healthcare professional.
From time to time the Practitioner may recommend that I consult one or more other healthcare professionals, including general practitioners, medical specialists, dietitians, biokineticists, psychologists, physiotherapists or other allied health practitioners.
Referral recommendations are made for my benefit. Choice of provider, the booking of any consultation, attendance, payment and the conduct of the consultation are my responsibility.
Longaevitas does not assume responsibility for, and is not vicariously liable in respect of, the care, advice, treatment, charges, availability or conduct of any external healthcare professional whom I consult, whether on referral or otherwise.
11. Member Acknowledgements
What preventative care can and cannot achieve over time.
I confirm my understanding that:
(a) preventative care can meaningfully reduce risk but cannot eliminate disease, ageing or death;
(b) clinical guidance evolves as scientific evidence changes, and recommendations issued today may be revised in future iterations of my VitaPrint;
(c) long-term, periodic monitoring and re-assessment is materially more beneficial than any single assessment in isolation; and
(d) no guarantee is made, expressly or by implication, regarding any specific health outcome, biomarker change, longevity benefit or absence of future disease.
12. Consent for Clinical Communication
How Longaevitas may communicate clinical information to you.
I consent to receive the following clinical and service communications from Longaevitas and the Practitioner through secure electronic means (including in-platform messaging, email, SMS and PDF attachments accessible through my account): my VitaPrint and any updates thereto; doctor-led recommendations; educational material relevant to my care; laboratory and investigation requests; referral letters; appointment, follow-up and reminder communications; and other clinical follow-up communications related to my care.
I understand that electronic communication is not perfectly secure; Longaevitas applies reasonable technical and organisational measures (encryption in transit and at rest, access control, audit logging) but cannot eliminate every risk associated with internet-based communication. I may at any time request that a specific communication be delivered in an alternative form.
13. Data Privacy (POPIA)
How your Personal and Special Personal Information is collected, processed, shared, retained and protected.
Longaevitas is the responsible party for the processing of your Personal Information and Special Personal Information (which includes your health information) under POPIA.
Lawful basis. We process your information on the lawful grounds of your express consent, the performance of this Consent, compliance with legal obligation, and our legitimate interest in operating the Services safely and securely.
What we collect. Identification and contact details, demographic information, account preferences, assessment answers, body measurements, biomarker results, uploaded laboratory reports, payment metadata, and technical or usage data.
Why we process. To provide the Services; to enable the Practitioner to issue a Doctor-led VitaPrint Analysis; to generate your VitaPrint and recommendations; to manage referrals, payouts and account administration; to send clinical and service communications; and to comply with legal, regulatory and professional obligations.
Sharing. We share Personal Information only with: the Practitioner reviewing your information; healthcare professionals directly involved in your care, on your instruction; laboratories and imaging providers involved in your care; payment partners; secure technology providers acting on our behalf under written processing agreements; and regulators or law-enforcement agencies where required by law. We do not sell your Personal Information.
Cross-border processing. Where Personal Information is processed outside the Republic of South Africa, we apply the safeguards required by section 72 of POPIA.
Security. We implement appropriate technical and organisational measures to safeguard your information, including encryption in transit and at rest, access control, role-based permissions, audit logging, staff confidentiality undertakings and regular review.
Retention. Your health-related information is retained for the period required to operate the Services and to comply with the National Health Act, HPCSA guidance and other applicable law. Standard retention is the longer of (i) six years after your last interaction with the Services and (ii) any longer statutory period, including the extended periods that apply to records of minors and of persons under legal disability, and to records relevant to a claim, complaint or investigation of which we are aware. Identifiers are removed once the retention period lapses, save where ongoing retention is required by law.
Security compromises. If a security compromise occurs in which there are reasonable grounds to believe your Personal Information has been accessed or acquired by an unauthorised person, we will notify the Information Regulator and you as soon as reasonably possible after discovering the compromise and establishing its scope, in accordance with section 22 of POPIA. The notification will describe the possible consequences, the measures we have taken or intend to take, and what you can do to reduce any adverse effects.
Your rights. You have the right to access, correct, delete, object to or restrict the processing of your information, to data portability where applicable, to withdraw your consent (subject to the legal and clinical consequences of withdrawal), and to lodge a complaint with the Information Regulator (South Africa) at JD House, 27 Stiemens Street, Braamfontein, Johannesburg; complaints.IR@justice.gov.za. To exercise any right, contact support@longaevitashealth.com.
13A. Vita Cohort Learning and De-identified Insights
How Vita learns from member trends, and your right to opt out at any time.
Vita is the Longaevitas platform assistant. To keep educational guidance current and relevant, Longaevitas analyses de-identified trends across the member community, including changes in assessment answers, body metrics, biomarker values, and outcomes following supplement or plan recommendations. This analysis produces cohort-level insights that inform the educational content Vita presents to members and the protocols doctor-led practitioners choose to consider. It does not diagnose, prescribe or replace clinical judgement.
Before your information is used for this cohort learning, it is de-identified (direct identifiers such as name, contact details and account identifiers are removed) and only aggregated results are used. No individual member is identifiable in the cohort insights that reach Vita, doctors, staff or any downstream user. Longaevitas will not sell your information and will not use it to train third-party artificial intelligence models.
Opt-out. Cohort learning is on by default when you join. You may withdraw at any time from Account > Privacy, and your future data will no longer be included in cohort learning. Withdrawal does not affect the doctor-led clinical care you receive through the Services, and cohort insights already generated from historic de-identified data cannot be reversed once aggregated.
Educational, not clinical. Cohort insights are educational proxies. They inform what Vita may surface and what doctors may consider, but every clinical decision remains with an HPCSA-registered Practitioner and, ultimately, your own treating doctor.
14. Clinical Records
Longaevitas maintains your clinical records as required by South African law.
I consent to Longaevitas maintaining comprehensive clinical records of my interactions with the Services, including my Health Assessment answers, biomarker results, VitaPrint Cycles, doctor-led analyses, communications, referrals and any associated audit data, in accordance with the National Health Act, the HPCSA ethical guidelines on the keeping of patient records, and POPIA.
Clinical records are retained for the periods required by law and applicable professional guidance. Subject to the National Health Act and POPIA, I have the right to request a copy of, or correction to, my clinical records by contacting support@longaevitashealth.com.
15. Third-Party Providers
External services Longaevitas relies on, and the limits of our responsibility for them.
The Services depend on independent third-party providers, including pathology laboratories, sample-collection partners, imaging providers and specialist healthcare professionals. While Longaevitas selects partners with reasonable care, it does not control their day-to-day operations.
Longaevitas is not responsible for, and accepts no liability arising from, delays, errors or service interruptions on the part of any laboratory, specialist or other third-party provider, or for the unavailability of any external service. Where such an issue occurs, Longaevitas will use reasonable endeavours to assist in resolving it.
16. Limitation of Liability
Drafted to be reasonable, transparent and CPA-compliant - with carve-outs for what cannot lawfully be excluded.
This clause is drawn to your attention in accordance with section 49 of the CPA. Please read it carefully. It limits the liability of Longaevitas and its associated persons.
To the maximum extent permitted by law, Longaevitas, its directors, officers, employees, contractors, the Practitioners, affiliates, secure technology providers and partner organisations (collectively, the "Indemnified Parties") shall not be liable for: (a) any indirect, incidental, special, consequential, exemplary or punitive loss or damage; (b) loss of profits, loss of revenue, loss of opportunity, loss of data or loss of goodwill; (c) any loss or damage arising from your failure to disclose accurate, complete or current information; (d) any loss or damage arising from your failure to seek emergency or other in-person medical care when indicated; (e) any loss or damage arising from the acts, omissions, delays, errors or service interruptions of any third-party provider; or (f) any loss or damage arising from your reliance on the Services contrary to the warnings contained in this Consent.
The total aggregate liability of all Indemnified Parties, taken together, arising from or in connection with the Services, regardless of the form of action, shall not exceed the greater of (i) the aggregate amounts actually paid by you to Longaevitas in the twelve (12) months immediately preceding the event giving rise to the claim and (ii) ZAR 5 000 (five thousand Rand).
Nothing in this Consent excludes or limits liability that cannot lawfully be excluded or limited under South African law, including liability for fraud, intentional wrongful conduct, gross negligence, death or personal injury where liability cannot lawfully be excluded under the CPA or the common law, or any other statutory liability that cannot be excluded.
17. Indemnity
Members indemnify Longaevitas for losses arising from inaccurate disclosure or misuse, within the limits SA law allows.
To the maximum extent permitted by law, I indemnify and hold harmless the Indemnified Parties (as defined above) from and against all claims, demands, actions, losses, damages, costs and expenses (including reasonable legal costs on the attorney-and-own-client scale) arising directly or indirectly out of: (a) inaccurate, incomplete or untrue information I provide through the Services; (b) my failure to disclose material health information; (c) my failure to seek appropriate or emergency medical care; (d) my use of the Services contrary to the warnings contained in this Consent or in any communication issued to me by the Practitioner; or (e) my breach of any provision of this Consent.
This indemnity does not apply to the extent that the loss arises from the fraud, gross negligence or wilful misconduct of an Indemnified Party.
18. Intellectual Property
Longaevitas owns its reports, frameworks and methodology; you receive a personal licence to use them.
All intellectual property in the Services - including reports, VitaPrints, risk scoring, educational material, clinical frameworks, decision logic, assessment methodology, written content, graphics, software and trade marks - is and remains the exclusive property of Longaevitas Health (Pty) Ltd or its licensors.
Longaevitas grants you a personal, limited, non-exclusive, non-transferable and revocable licence to access and use the outputs of the Services for your own personal preventative healthcare purposes. You may not copy, reproduce, modify, distribute, publish, commercialise or create derivative works from the Services or their outputs without the prior written consent of Longaevitas, save where such use is permitted by law.
19. Telehealth Consent
Consent for remote consultations, virtual review, digital documents and electronic signatures (ECTA).
I consent to the conduct of my care through asynchronous telehealth, including: remote consultations; written and electronic communication; virtual review of my Health Assessment, body composition and biomarker information by the Practitioner; digital delivery of VitaPrints, reports, referral letters, supplement guidance and other documents; and the use of electronic signatures within the meaning of section 13 of ECTA.
I understand that asynchronous telehealth has limitations relative to in-person care, including the absence of physical examination, and that the Practitioner may decline to issue a recommendation, or may require me to attend an in-person consultation, where in the Practitioner's clinical judgement that is appropriate. The HPCSA ethical guidelines on telemedicine apply to my care.
20. Medical Conditions Requiring Immediate Care
I am not currently experiencing emergency symptoms - and I will seek emergency care if I do.
I confirm that at the time of completing this Consent I am not experiencing, and am not aware of any active suspicion of, symptoms that require emergency medical assessment, including but not limited to: chest pain or pressure; signs of stroke (facial droop, arm weakness, speech disturbance, sudden severe headache); loss of consciousness or fainting; acute severe shortness of breath; major trauma; severe or uncontrolled bleeding; seizures or convulsions; acute confusion or disorientation; suicidal thoughts or thoughts of harming myself or others; or any other rapidly worsening medical condition.
If at any time after completing this Consent I develop any such symptom, I will immediately seek emergency care by telephoning 112 from a mobile telephone or 10177 from a landline, or by attending the nearest emergency department, and I will not wait for or rely upon any communication through the Services.
21. Final Consent Confirmation
Final declaration and electronic signature.
I confirm that:
(a) I have read every section of this Consent;
(b) I have understood the information set out, or had it explained to me, in a language and form I understand;
(c) I have had the opportunity to ask questions and to obtain independent advice if I wished;
(d) I provide my consent freely and voluntarily, without coercion or undue influence;
(e) I understand the risks, limitations and uncertainties associated with the Services as set out above;
(f) I have read, understood and agree to the Longaevitas Terms of Service and Privacy Policy as currently published;
(g) I confirm that the full legal name I have entered below is mine, and that affixing it by typing it into the signature field constitutes my electronic signature for the purposes of section 13 of ECTA, with the same legal effect as a handwritten signature; and
(h) I authorise Longaevitas to retain a timestamped, immutable record of this Consent, together with the date, time, version, IP address and device information of submission, as part of my clinical record.
These terms are drafted for South African law. They are subject to review by our appointed South African healthcare attorney; the current version is provided for transparency and does not constitute legal advice. Questions: support@longaevitashealth.com.